REQUEST A DEMO
Total
USD $0.00
Search more companies

Dx & Vx Co., Ltd. (South Korea)

Main Activities: Miscellaneous Manufacturing | Testing Laboratories
Full name: Dx & Vx Co., Ltd. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the molecular diagnostics business. The Company mainly provides deoxyribonucleic acid (DNA) chips, whole genome amplification systems, noninvasive prenatal testing chips and others. The Company was established on Jun 16, 2001. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 20, 2015.

Headquarters
1003 173 Digital-Ro, Geumcheon-Gu
Seoul; Seoul; Postal Code: 08511

Contact Details: Purchase the Dx & Vx Co., Ltd. report to view the information.

Website: http://www.mgmed.co.kr

Basic Information
Total Employees:
Purchase the Dx & Vx Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Dx & Vx Co., Ltd. report to view the information.
Registered Capital:
Purchase the Dx & Vx Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Dx & Vx Co., Ltd. report to view the information.
Incorporation Date:
June 16, 2001
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Technology Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
5.8%
Purchase this report to view the information.
3.2%
Purchase this report to view the information.
0.2%
Subsidiaries
(주)엠제이셀바이오
50%
Oxford Vacmedix Uk Limited
43.46%
Oxford Cancer Biomarkers Limit
14.14%
Company Performance
Financial values in the chart are available after Dx & Vx Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
45.24%
Total operating revenue
49.72%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
-2770.27%
Total assets
16.27%
Total equity
-16.17%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-56.54%
Return on Equity (ROE)
-93.84%
Debt to Equity Ratio
35.07%
Quick Ratio
-0.77%
Cash Ratio
-0.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?